<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">27153554</PMID>
        <DateCompleted>
            <Year>2017</Year>
            <Month>12</Month>
            <Day>27</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1949-2553</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <Issue>24</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Jun</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Oncotarget</Title>
                <ISOAbbreviation>Oncotarget</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Functional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death.</ArticleTitle>
            <Pagination>
                <MedlinePgn>36138-36153</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.9147</ELocationID>
            <Abstract>
                <AbstractText>A critical first step in the personalized approach to cancer treatment is the identification of activated oncogenes that drive each tumor. The Identification of driver oncogenes on a patient-by-patient basis is complicated by the complexity of the cancer genome and the fact that a particular genetic alteration may serve as a driver event only in a subset of tumors that harbor it. In this study, we set out to identify the complete set of functional oncogenes in a small panel of breast cancer cell lines. The cell lines in this panel were chosen because they each contain a known receptor tyrosine kinase (RTK) oncogene. To identify additional drivers, we integrated functional genetic screens with copy number and mutation analysis, and cancer genome knowledge databases. The resulting functional oncogene signatures were able to predict responsiveness of cell lines to targeted inhibitors. However, as single agents, these drugs had little effect on clonogenic potential. By contrast, treatment with drug combinations that targeted multiple oncogenes in the signatures, even at very low doses, resulted in the induction of apoptosis and striking synergistic effects on clonogenicity. In particular, targeting a driver oncogene that mediates AKT phosphorylation in combination with targeting the anti-apoptotic BCL2L1 protein had profound effects on cell viability. Importantly, because the synergistic induction of cell death was achieved using low levels of each individual drug, it suggests that a therapeutic strategy based on this approach could avoid the toxicities that have been associated with the combined use of multiple-targeted agents.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Guest</LastName>
                    <ForeName>Stephen T</ForeName>
                    <Initials>ST</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kratche</LastName>
                    <ForeName>Zachary R</ForeName>
                    <Initials>ZR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Irish</LastName>
                    <ForeName>Jonathan C</ForeName>
                    <Initials>JC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wilson</LastName>
                    <ForeName>Robert C</ForeName>
                    <Initials>RC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haddad</LastName>
                    <ForeName>Ramsi</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gray</LastName>
                    <ForeName>Joe W</ForeName>
                    <Initials>JW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Garrett-Mayer</LastName>
                    <ForeName>Elizabeth</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Public Health Science, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ethier</LastName>
                    <ForeName>Stephen P</ForeName>
                    <Initials>SP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>P30 CA138313</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>T32 CA009531</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Oncotarget</MedlineTA>
            <NlmUniqueID>101532965</NlmUniqueID>
            <ISSNLinking>1949-2553</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015513">Oncogene Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D054852">Small Molecule Libraries</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.10.1</RegistryNumber>
                <NameOfSubstance UI="D020794">Receptor Protein-Tyrosine Kinases</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004354" MajorTopicYN="N">Drug Screening Assays, Antitumor</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004357" MajorTopicYN="N">Drug Synergism</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058990" MajorTopicYN="N">Molecular Targeted Therapy</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015513" MajorTopicYN="N">Oncogene Proteins</DescriptorName>
                <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020794" MajorTopicYN="N">Receptor Protein-Tyrosine Kinases</DescriptorName>
                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D054852" MajorTopicYN="N">Small Molecule Libraries</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">AKT</Keyword>
            <Keyword MajorTopicYN="N">BCL2L1</Keyword>
            <Keyword MajorTopicYN="N">FGFR</Keyword>
            <Keyword MajorTopicYN="N">breast cancer</Keyword>
            <Keyword MajorTopicYN="N">functional genomics</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>01</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>04</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>5</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>12</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>5</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27153554</ArticleId>
            <ArticleId IdType="pii">9147</ArticleId>
            <ArticleId IdType="doi">10.18632/oncotarget.9147</ArticleId>
            <ArticleId IdType="pmc">PMC5094989</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2015 Sep 22;6:8305</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26392303</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 1990 Sep 15;50(18):6087-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1697506</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2015 Jan 1;372(1):30-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25399551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mammary Gland Biol Neoplasia. 1996 Jan;1(1):111-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10887484</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D805-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25355519</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2004 Nov 1;64(21):7678-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15520168</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Discov Today. 2003 Dec 15;8(24):1104-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14678733</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 2007 Sep 15;121(6):1265-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17520678</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Rev. 2003 Sep;55(3):401-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12869662</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Oncol. 2015 Feb;9(2):527-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25454348</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2015 Aug 28;10(8):e0136407</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26317216</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 1993 Feb 1;53(3):627-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8425198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2007 Oct 15;67(20):9887-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17942920</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2013 Jul 1;19(13):3693-702</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23658459</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Elife. 2013 Jun 25;2:e00747</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23805382</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Cell Res. 2015 Mar 15;332(2):223-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25704758</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2008 May 1;68(9):3421-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18451170</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Res. 2012 Mar;22(3):568-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22300766</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2014 Nov 13;371(20):1877-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25265492</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neoplasia. 2014 Aug;16(8):644-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25220592</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2011 Mar 10;364(10):947-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21388312</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 1998 Oct 15;17(20):5896-904</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9774334</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 1999 Dec;81(8):1328-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10604729</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2010 Feb 18;463(7283):899-905</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20164920</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncotarget. 2014 Oct 15;5(19):9039-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25344863</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer Res. 2004 Nov;2(11):643-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15561780</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Biol. 2011;12(4):R41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21527027</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2016 Mar 10;34(8):871-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26811525</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2000 Nov 1;60(21):6101-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11085534</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Biol Ther. 2004 Aug;3(8):772-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15254419</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2004 Apr 23;304(5670):554</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15016963</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pathol. 2012 Feb;226(3):442-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22009326</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Diagn Ther. 2012 Dec;16(6):347-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23023732</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2001 Apr 5;344(14):1038-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11287973</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2011 Apr 1;17 (7):1658-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21447722</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Cell. 2007 Oct;12 (4):395-402</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17936563</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Physiol Genomics. 2014 Jul 1;46(13):448-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24824212</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Breast Cancer Res. 2000;2(4):311-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11056689</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 1997 Dec;3(12 Pt 2):2696-702</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10068276</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2012 Oct 4;490(7418):61-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23000897</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2001 Mar 15;344(11):783-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11248153</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2012 May 16;486(7403):400-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22722201</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 1999 Sep;17(9):2639-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10561337</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer. 2015 Jul 02;14:126</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26134786</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer Ther. 2004 Nov;3(11):1427-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15542782</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):12492-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26401016</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1519-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11121658</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Clin Oncol. 2010 Feb;7(2):98-107</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20027191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Cell. 2013 Jan 14;23(1):121-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23245996</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2002 Jul 5;297(5578):63-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12098689</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer Ther. 2011 Dec;10(12):2340-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21914853</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Pharmacol Sci. 2005 Feb;26(2):77-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15681024</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):802-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15647370</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 1996 May;2(5):561-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8616716</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2015 Feb 19;372(8):724-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25693012</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2008 Dec 15;112(13):4808-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19064740</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>